Hydrochloric Acid → Morpholino-[3-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazin-1-yl]methanone hydrochloride
Reaktionsgleichung
[N:1]1([C:7]([C:9]2[N:10]=[C:11]([C:25]([F:28])([F:27])[F:26])[N:12]3[CH2:17][CH2:16][N:15](C(OC(C)(C)C)=O)[CH2:14][C:13]=23)=[O:8])[CH2:6][CH2:5][O:4][CH2:3][CH2:2]1.[ClH:29]>O1CCOCC1>[ClH:29].[O:4]1[CH2:5][CH2:6][N:1]([C:7]([C:9]2[N:10]=[C:11]([C:25]([F:27])([F:28])[F:26])[N:12]3[CH2:17][CH2:16][NH:15][CH2:14][C:13]=23)=[O:8])[CH2:2][CH2:3]1Komponenten
4
Edukt 2
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
Tert-butyl 1-(morpholine-4-carbonyl)-3-(trifluoromethyl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-7-carboxylate 20b (470 mg, 1.27 mmol) was dissolved in 20 mL of a 2 M solution of hydrogen chloride in 1,4-dioxane. After stirring for 12 hours, the reaction mixture was concentrated under reduced pressure to obtain crude morpholino-[3-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazin-1-yl]methanone hydrochloride 20c (300 mg) as a light yellow oil. The product was used directly in the next reaction without purification.
Aufarbeitung
- concentrationthe reaction mixture was concentrated under reduced pressure
Quellen und Nachweise
- ORD-Eintrag
- ord-80e7ecbbfffb4215ae1e2fa3bbd11f8a
- Quelldatensatz
- uspto-grants-2016_03
- Patentnummer
- US09273052B2
Notizen zur Reaktion
Wird geladen…